# Medullary Thyroid Carcinoma

Top podkast episoder
Oppdatert:

Medullary Thyroid Carcinoma: A Surgeon’s Perspective with Dr. Lorenz

This two-part episode focuses on surgical decision making in medullary thyroid carcinoma, from patient selection to preoperative workup. Dr. Kerstin Lorenz explains how calcitonin levels, ultrasound findings and genetic considerations shape staging, imaging choices and the initial extent of surgery…

69: GLP-1s Are Not Just for Weight Loss - The Smarter Microdosing Strategy for Metabolism Muscle and Long Term Health with McCall McPherson

What if GLP-1 medications work best not at higher doses, but with slower, personalized microdosing? In this solo Ask Me Anything episode of Modern Thyroid and Wellness, McCall McPherson answers your most pressing questions about GLP-1 medications. Drawing from clinical experience and current resear…

Clinical Challenges in Endocrine Surgery: Medullar Thyroid Cancer with Special Guest Dr. Kepal Patel

In this episode from the Endocrine Surgery team at BTK we invited Dr. Kepal Patel to join us to discuss two endocrine surgery cases while discussing pertinent literature. We discuss the work-up and surgical decision making for a case of medullary thyroid cancer and a Bethesda III thyroid nodule.   …

Behind the Knife ABSITE 2026 - Quick Hits 1

Behind the Knife ABSITE 2026 – Up-to-date and high yield learning to help you DOMINATE the exam.Don’t forget to check out our ABSITE Podcast Companion Book available on Amazon: https://www.amazon.com/Behind-Knife-ABSITE-Podcast-Companion/dp/B0CLDQWZG3/ref=monarch_sidesheetBe sure to check out our f…

GLP-1s and Peptides for Hashimoto’s Hypothyroidism: What You Must Know Before Starting Peptides

In this must-listen episode of Hashimoto’s Nutrition Rx, Nataliia Sanzo, RDN, chats with thyroid and metabolic expert McCall McPherson, PA-C, to break down everything you need to know before considering peptides or GLP-1 meds for Hashimoto’s hypothyroidism.  You’ll hear real-life experiences, clini…

Cardiovascular Impact of Diabetes Meds

Listen in as our expert panel discusses which diabetes meds have cardiovascular (CV) benefits.  We’ll review the evidence and discuss the pros and cons of SGLT2 inhibitors (dapagliflozin, empagliflozin, etc) and GLP-1 agonists (dulaglutide, semaglutide, etc) in patients with or at risk for CV disea…

Landmark Tobacco Settlement in Canada and FDA Greenlights Generic GLP-1 for Weight Loss

In this episode, Dr. Chi-Ming Chow begins with a welcome and introduction to the day's topics. The discussion starts with an in-depth look at the landmark tobacco settlement in Canada, including the details of the agreement, how the funds will be distributed, and the broader public health implicati…

Episode 96 - Tirzepatide

Episode 96: Tirzepatide.  By Maria Beuca, MS3, Ross University School of Medicine. Comments by Hector Arreaza, MD.    Today is May 19, 2022, and we want to talk about a new drug that was recently approved by the FDA on May 13, 2022, for the treatment of type 2 diabetes.    This is Rio Bravo qWeek P…

Clinical Challenges in Endocrine Surgery: Genetic Testing for Thyroid Cancer

In this episode from the Endocrine Surgery team at BTK we discuss the clinical applications of genetic testing for thyroid cancer. We walk through three cases of thyroid nodules and discuss why and how genetic testing can guide surgical and medical management. As usual we review key points such as …

Two Ts Presents: Two Jersey Js: Jackie’s Turn

Jackie responds to Kelly Osbourne’s recent comments on Ozempic. Is what she said dangerous?  Jackie shares her concerns and more.  See omnystudio.com/listener for privacy information.